Phase 2 Chronic Kidney Disease Trial, Recruiting NCT06225544 Sponsor: Charite University, Berlin, Germany Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Phase 2 Chronic Kidney Disease Trial, Recruiting

NCT06225544
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male or female, aged between 18 and 80 years old.
  • If you are a woman who could become pregnant, you agree to either avoid sex or use contraception throughout the study.
  • You are able to understand the study and give written consent to take part after being fully informed about what it involves.
  • You have been on haemodialysis (kidney dialysis) for at least 2 months and your treatment is stable.
  • You attend haemodialysis three times per week.
  • You have a permanent dialysis access point, such as a fistula, graft, or a long-term dialysis catheter.
  • Your kidney failure was not caused by a condition called primary hyperoxaluria.
  • Your blood oxalate level (a naturally occurring substance measured in your blood) is at or above a certain level (≥20 μmol/L).
  • You have not had any major changes to your regular medicines or diet in the last 2 months.

Who may not be able to join:

  • You have been diagnosed with a condition called primary hyperoxaluria (types 1, 2, or 3), or have a known gene change that causes it.
  • You have been on haemodialysis for less than 2 months.
  • You are on peritoneal dialysis (a different type of dialysis) instead of, or as well as, haemodialysis.
  • Your dialysis access is temporary or not working well.
  • You are pregnant, planning to become pregnant, or currently breastfeeding.
  • You have a bowel or digestive condition such as Inflammatory Bowel Disease, short gut syndrome, or a condition that affects how your gut absorbs nutrients.
  • You have severe liver failure.
  • You currently have an active infection or are taking antibiotics.
  • You are currently taking more than 250mg of Vitamin C per day.
  • You have a terminal illness or are not expected to live for more than 1 year.
  • You have a psychiatric (mental health) condition that is currently uncontrolled and would make it difficult to follow the study requirements.
  • You are under an institutional order from a court or government.
  • You may be in a situation where you could feel pressured into joining the study due to a relationship with those running it (confirm with trial site).
  • Your liver function blood test results are significantly abnormal — specifically, certain liver enzyme levels are more than twice the normal upper limit (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Felix Knauf, MD, Charite Universitätsmedizin

Phone: + 49 030 450 530067

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
14 April 2024
Est. completion
30 January 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Pre-dialysis Plasma Oxalate concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov